Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

AstraZeneca PLC (GB:AZN)

LSE:AZN

UK Market

AZN

AstraZeneca

Analyst Forecasts

News & Insights

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Holding GB:AZN?

Track your performance easily

AstraZeneca (AZN) Stock News & Sentiment

568 Followers

Enhertu Gains US FDA Approval for Broader Breast Cancer Treatment

Company Announcements

Enhertu Gains US FDA Approval for Broader Breast Cancer Treatment

3d ago

AstraZeneca’s Datroway Gains US Approval for Advanced Breast Cancer Treatment

Company Announcements

AstraZeneca’s Datroway Gains US Approval for Advanced Breast Cancer Treatment

11d ago

AstraZeneca’s Calquence Wins FDA Approval for Mantle Cell Lymphoma

Market News

AstraZeneca’s Calquence Wins FDA Approval for Mantle Cell Lymphoma

13d ago

AstraZeneca’s Calquence Gains FDA Approval for First-Line Mantle Cell Lymphoma Treatment

Company Announcements

AstraZeneca’s Calquence Gains FDA Approval for First-Line Mantle Cell Lymphoma Treatment

14d ago

AstraZeneca Announces Share Capital and Voting Rights Update

Company Announcements

AstraZeneca Announces Share Capital and Voting Rights Update

28d ago

Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders

Class Action

Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders

1M ago

AstraZeneca Withdraws EU Application for Lung Cancer Drug

Company Announcements

AstraZeneca Withdraws EU Application for Lung Cancer Drug

1M ago

More GB:AZN News >

AZN News on the Web

2025-01-29

Astrazeneca Rises As Market Takes a Dip: Key Facts

Yahoo Finance

Neutral

2025-01-29

FDA expands Enhertu approval to include HER2-ultralow breast cancer patients

Pharmaceutical Technology

Neutral

2025-01-29

Should AstraZeneca Stock Be in Your Portfolio Pre-Q4 Earnings?

Yahoo Finance

Neutral

2025-01-29

Here's Why Astrazeneca is a Strong Value Stock

Yahoo Finance

Neutral

2025-01-28

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

Yahoo Finance

Neutral

2025-01-27

ENHERTU® approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies

Yahoo Finance

Neutral

2025-01-24

Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug

Yahoo Finance

Neutral

2025-01-24

Here's Why Astrazeneca is a Strong Growth Stock

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

GB:AZN

Sector Average

Media Buzz

This Week8 articles

Weekly Average7.75 articles

News Sentiment

This Week50%

Sector Average64%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:AZN’s Media Buzz Sentiment?

8 articles about GB:AZN were published this week. In an average week, 7.75 articles are published.

What is GB:AZN’s weekly average amount of articles?

In an average week, 7.75 articles about GB:AZN are published.

What is GB:AZN’s News Sentiment?

50% of articles about GB:AZN were positive this week, compared to its sector average of 64%.

Healthcare Stocks that are Trending in the News

LNTHLantheus

CORTCorcept Therapeutics

INBSIntelligent Bio Solutions

AGLANGLE plc

AKROAkero Therapeutics

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing